Heparin cofactor II in diabetic patients

Levels of heparin cofactor II (HCII) activity and antigen and electrophoretic pattern were studied both in normal subjects and in type I diabetic patients with high and normal levels of glycosylated haemoglobin. There was a significant reduction in HCII activity (83±7%) in patients with high levels...

Descripción completa

Guardado en:
Detalles Bibliográficos
Publicado: 1994
Materias:
crossed immunoelectrophoresis
diabetes
heparin cofactor II
glycosylated hemoglobin
adult
article
controlled study
diabetes mellitus
female
human
immunoassay
major clinical study
male
priority journal
Acceso en línea:https://bibliotecadigital.exactas.uba.ar/collection/paper/document/paper_09575235_v5_n2_p201_Duboscq
http://hdl.handle.net/20.500.12110/paper_09575235_v5_n2_p201_Duboscq
Aporte de:
Biblioteca Digital - Facultad de Ciencias Exactas y Naturales (UBA) de Universidad de Buenos Aires
Descripción
Sumario:Levels of heparin cofactor II (HCII) activity and antigen and electrophoretic pattern were studied both in normal subjects and in type I diabetic patients with high and normal levels of glycosylated haemoglobin. There was a significant reduction in HCII activity (83±7%) in patients with high levels of glycosylated haemoglobin compared with controls (95±17%; P<0.001). However, plasma HCII antigen levels were not decreased in these patients.

Ejemplares similares